openPR Logo
Press release

Atrial Fibrillation Devices Market 2020 Top Players - AtriCure, Inc., Abbott Laboratories (St. Jude Medical), BIOTRONIK, Boston Scientific Corporation, CardioFocus, Inc., Hansen Medical, Johnson and Johnson (Biosense Webster), Medtronic plc, Siemens Healt

05-20-2020 05:02 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Atrial Fibrillation Devices Market

Atrial Fibrillation Devices Market

Atrial Fibrillation Devices Market will exceed USD 12.5 billion by 2025; as per a new research report.

Rise in adoption rate of enhanced technologies coupled with availability of sophisticated healthcare infrastructure will boost atrial fibrillation devices industry growth across the globe. Presence of reimbursement scenario in developed regions will further propel industry expansion. Moreover, rising prevalence of cardiovascular diseases owing to sudden transition of lifestyle and growing trends of tobacco intake in millennials will prove to be high market impact rendering factor. Continuous growth in geriatric population is another reason responsible for upward trajectory of atrial fibrillation market growth.

Currently, high cost associated with the application of atrial fibrillation devices will act as a market restraining factor. Additionally, poor health care access in some parts of under developed regions and lack of awareness about latest technological advents are few major hindrances for the market growth.

Request sample copy of this report @

EP ablation catheters market is forecasted to witness a lucrative CAGR of 14.4% over the forecast period. Ablation catheters are most extensively used across the globe owing to increasing preference for minimally invasive surgeries. Furthermore, adoption rate of catheter ablation system is high due to increasing success rate of paroxysmal, persistent and permanent conditions of atrial fibrillation procedures. Venture capital investment in research and development of such devices is another market augmenting factor.

Hospitals as an end-use held significant market share and was valued at around USD 2,483.4 million in the year 2018. The hospital end-use segment is dominating the atrial fibrillation devices market owing to increasing number of multi-specialty hospitals and people's preference for hospitals over other healthcare facilities. Moreover, procedures related to atrial fibrillation are mostly performed in hospital settings. Hence, the demand for atrial fibrillation devices are highest in hospitals as compared to other healthcare facilities. Increasing number of hospitals admissions for atrial fibrillation in developed countries will strongly drive the segment growth in the coming years.

U.S atrial fibrillation devices market will witness a growth at 13.9% during the forecast period. Availability of cutting-edge technologies and rising healthcare expenditure in the U.S. will enable efficient growth of atrial fibrillation devices market. With growing popularity of these systems, more and more installations are anticipated to take place during the projection years.

Make Inquiry about this report @

China atrial fibrillation devices market was valued at around USD 324.7 million in the year 2018. The region provides lucrative growth opportunity owing to rising prevalence of cardiovascular diseases in the country. Growing healthcare expenditure of China and citizen's financial position will propel industry growth over the forecast period.

Industry players having a strong foothold in the global market include Abbott Laboratories, Johnson & Johnson, Atricure Inc., Microport Scientific Corporation and Boston Scientific Corporation. Other notable participants include St. Jude medical, Inc., Medtronic Plc, Koninklijke Philips N.V., Siemens AG. Etc. Several well-known firms are entering in sparsely addressed high potential geographies in order to expand their market presence. Innovative product launch in developing economies by these companies permits them to cater to unmet needs of the patient population and hence, expand revenue bases.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atrial Fibrillation Devices Market 2020 Top Players - AtriCure, Inc., Abbott Laboratories (St. Jude Medical), BIOTRONIK, Boston Scientific Corporation, CardioFocus, Inc., Hansen Medical, Johnson and Johnson (Biosense Webster), Medtronic plc, Siemens Healt here

News-ID: 2051651 • Views: 586

More Releases from Global Market Insights, Inc.

Hypochlorite Bleaches Market to hit US$ 300 Mn 2025 | Top Key Players like Adity …
As per the research report by Global Market Insights, Inc., Global Hypochlorite Bleaches Market to cross USD 300 million by 2025 and grow at 3.4% CAGR from 2019 to 2025. It has been projected that the Global hypochlorite bleaches market is expected to reach a consumption of around 485-kilo tons by 2025. Water scarcity as well as rising water costs have led to more emphasis being laid on water recycling and
Feminine Hygiene Products Market: Growing awareness regarding intimate health in …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Feminine Hygiene Products Market. One of the most hushed topics across the world is female hygiene, the negligence of which results in several diseases. Studies claim that nearly 30% to 60 % women across the globe develop urinary tract infection once in their lifetime, mainly due to negligence in proper intimate hygiene. Dearth of knowledge regarding the negative consequences of
Examination Gowns Market 2020 business trends & growth opportunities to 2026
Global Market Insights, Inc., announces an ongoing comprehensive report on the Examination Gowns Market. The exposure to various kinds of hospital acquired infections has led to a spate of health problems for the healthcare professionals as well has the patients. In this regard, experts have been massively shifting to adoption of personal protective equipment or clothing, examination gowns, protecting them from all kinds of infections. These gowns are present in the
Nonwoven Packaging Market to witness increased demand from pharmaceutical sector …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Nonwoven Packaging Market. With the world struggling to fight against negative consequences of industrialization and increased carbon emissions, nonwovens or nonwoven fabrics have emerged as an intrinsic solution for all ecological imbalances across the globe. These fabrics are made from staple fiber and long fibers, merged together by chemical, heat, or mechanical treatment. These are generally used in textile manufacturing

All 5 Releases

More Releases for Atrial

Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness. Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated
Atrial Septal Defect Market Future Opportunities2017 - 2025
Global Atrial Septal Defect Market: Outlook Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole
Atrial Flutter Market Progresses For Huge Profits During 2025
Atrial flutter is abnormal heart rhythm. It is characterized by atrial rates of 240 to 400 beats per minute and blockage in atrioventricular node. Atrioventricular node controls the heart rate and is one of the major elements in the cardiac conduction system. Atrial flutter leads to irregular electrical impulse of the heart resulting in disorganized contraction in parts of heart and disability to pump required amount of blood. The common
Atrial Fibrillation - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atrial Fibrillation - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Pipeline Review, H2 2017, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body.